SI2132204T1 - Kristalinične oblike 8-azabiciklo(3.2.1) oktanske spojine - Google Patents

Kristalinične oblike 8-azabiciklo(3.2.1) oktanske spojine

Info

Publication number
SI2132204T1
SI2132204T1 SI200830928T SI200830928T SI2132204T1 SI 2132204 T1 SI2132204 T1 SI 2132204T1 SI 200830928 T SI200830928 T SI 200830928T SI 200830928 T SI200830928 T SI 200830928T SI 2132204 T1 SI2132204 T1 SI 2132204T1
Authority
SI
Slovenia
Prior art keywords
compound
crystalline forms
crystalline
forms
Prior art date
Application number
SI200830928T
Other languages
English (en)
Inventor
Sean Dalziel
Leticia M. Preza
Miroslav Rapta
Pierre-Jean Colson
Original Assignee
Theravance, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39620376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2132204(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theravance, Inc. filed Critical Theravance, Inc.
Publication of SI2132204T1 publication Critical patent/SI2132204T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200830928T 2007-02-28 2008-02-27 Kristalinične oblike 8-azabiciklo(3.2.1) oktanske spojine SI2132204T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90409007P 2007-02-28 2007-02-28
EP08726162A EP2132204B1 (en) 2007-02-28 2008-02-27 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
PCT/US2008/002583 WO2008106159A1 (en) 2007-02-28 2008-02-27 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

Publications (1)

Publication Number Publication Date
SI2132204T1 true SI2132204T1 (sl) 2013-05-31

Family

ID=39620376

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830928T SI2132204T1 (sl) 2007-02-28 2008-02-27 Kristalinične oblike 8-azabiciklo(3.2.1) oktanske spojine

Country Status (27)

Country Link
US (7) US7943772B2 (sl)
EP (1) EP2132204B1 (sl)
JP (2) JP5512289B2 (sl)
KR (1) KR101480530B1 (sl)
CN (1) CN101616916B (sl)
AR (2) AR065554A1 (sl)
AU (1) AU2008219615B2 (sl)
BR (1) BRPI0807974B8 (sl)
CA (1) CA2678073C (sl)
CL (1) CL2008000573A1 (sl)
CO (1) CO6220856A2 (sl)
CY (1) CY1115077T1 (sl)
DK (1) DK2132204T3 (sl)
ES (1) ES2402031T3 (sl)
HK (1) HK1139399A1 (sl)
HR (1) HRP20130193T1 (sl)
IL (1) IL200131A (sl)
MX (1) MX2009009141A (sl)
MY (1) MY148318A (sl)
NZ (1) NZ578871A (sl)
PL (1) PL2132204T3 (sl)
PT (1) PT2132204E (sl)
RU (1) RU2458061C2 (sl)
SI (1) SI2132204T1 (sl)
TW (1) TWI409067B (sl)
WO (1) WO2008106159A1 (sl)
ZA (1) ZA200905832B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TWI409067B (zh) 2007-02-28 2013-09-21 Theravance Inc ８-氮雜雙環〔３．２．１〕辛烷化合物之結晶型
TWI415850B (zh) * 2007-07-20 2013-11-21 Theravance Inc 製備ｍｕ類鴉片受體拮抗劑之中間物的方法
WO2009029257A1 (en) * 2007-08-27 2009-03-05 Theravance, Inc. Disubstituted alkyl-8-azabicyclo [3.2.1.] octane compounds as mu opioid receptor antagonists
TWI423801B (zh) * 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之８－氮雜雙環〔３．２．１〕辛基－２－羥基苯甲醯胺化合物
EP2185553B1 (en) * 2007-08-27 2012-06-27 Theravance, Inc. Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
US7691878B2 (en) * 2007-08-27 2010-04-06 Theravance, Inc. Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TW201118084A (en) * 2009-09-18 2011-06-01 Adolor Corp The use of an opioid receptor antagonist for the treatment or prevention of gastrointestinal tract disorders
DK3277278T3 (da) * 2015-04-02 2020-04-06 Theravance Biopharma R&D Ip Llc Kombinationsdoseringsform af en my-opioid receptorantagonist og et opioid

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5159081A (en) 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
US6900228B1 (en) 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
GB9810671D0 (en) 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
TWI244481B (en) 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
US6467084B1 (en) * 1999-12-16 2002-10-15 Emware, Inc. Systems and methods for reprogramming an embedded device with program code using relocatable program code
AU2001241676A1 (en) 2000-03-03 2001-09-17 Ortho-Mcneil Pharmaceutical, Inc. 3-(diarylmethylene)-8-azabicyclo(3.2.1)octane derivatives
US20020025948A1 (en) 2000-06-23 2002-02-28 Banks Bernard Joseph 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
IL161157A0 (en) 2001-10-22 2004-08-31 Pfizer Prod Inc 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
US7381721B2 (en) 2003-03-17 2008-06-03 Adolor Corporation Substituted piperidine compounds
US20040204453A1 (en) 2003-04-14 2004-10-14 Pfizer Inc 4-Phenyl-piperidine compounds and their use as modulators of opioid receptors
US7056930B2 (en) 2003-04-14 2006-06-06 Pfizer Inc. 2-Azabicyclo[3.3.1]nonane derivatives
BRPI0409307A (pt) * 2003-04-14 2006-04-25 Pfizer Prod Inc derivados de 3-azabiciclo[3.2.1]octano
WO2004092165A1 (en) 2003-04-15 2004-10-28 Pfizer Products Inc. 3-benzhydrylidene-8-aza-bicyclo[3.2.1]octane derivatives with opioid receptor activity
US6992090B2 (en) 2003-06-16 2006-01-31 Adolor Corporation Substituted piperidine compounds and methods of their use
EP1737853A1 (en) 2004-02-03 2007-01-03 Janssen Pharmaceutica N.V. 3-(diheteroarylmethylene)-8-azabicyclo¬3.2.1|octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo¬3.2.1|octane derivatives
US7087749B2 (en) 2004-03-11 2006-08-08 Adolor Corporation Substituted piperidine compounds and methods of their use
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
CA2667259A1 (en) 2006-11-07 2008-05-15 Nektar Therapeutics Al, Corporation Dosage forms and co-administration of an opioid agonist and an opioid antagonist
TWI409067B (zh) * 2007-02-28 2013-09-21 Theravance Inc ８-氮雜雙環〔３．２．１〕辛烷化合物之結晶型

Also Published As

Publication number Publication date
HRP20130193T1 (hr) 2013-03-31
BRPI0807974B8 (pt) 2021-05-25
IL200131A0 (en) 2010-04-15
CO6220856A2 (es) 2010-11-19
MX2009009141A (es) 2009-09-03
AU2008219615A1 (en) 2008-09-04
RU2458061C2 (ru) 2012-08-10
CA2678073A1 (en) 2008-09-04
US20130072515A1 (en) 2013-03-21
PT2132204E (pt) 2013-03-25
US8247555B2 (en) 2012-08-21
ZA200905832B (en) 2010-05-26
US8536335B2 (en) 2013-09-17
DK2132204T3 (da) 2013-04-29
US7943772B2 (en) 2011-05-17
EP2132204B1 (en) 2013-01-23
MY148318A (en) 2013-03-29
US20150073014A1 (en) 2015-03-12
CA2678073C (en) 2016-01-05
BRPI0807974B1 (pt) 2020-11-24
NZ578871A (en) 2012-01-12
AR109224A2 (es) 2018-11-07
AR065554A1 (es) 2009-06-17
CL2008000573A1 (es) 2008-05-16
ES2402031T3 (es) 2013-04-26
JP5512289B2 (ja) 2014-06-04
US20180200246A1 (en) 2018-07-19
US20080207676A1 (en) 2008-08-28
KR20090115767A (ko) 2009-11-05
TWI409067B (zh) 2013-09-21
RU2009135834A (ru) 2011-04-10
CY1115077T1 (el) 2016-12-14
US9949963B2 (en) 2018-04-24
WO2008106159A1 (en) 2008-09-04
JP2013151564A (ja) 2013-08-08
US20140080856A1 (en) 2014-03-20
JP2010520198A (ja) 2010-06-10
IL200131A (en) 2013-03-24
CN101616916B (zh) 2011-10-12
BRPI0807974A2 (pt) 2014-09-16
US8816091B2 (en) 2014-08-26
US20160287572A1 (en) 2016-10-06
AU2008219615B2 (en) 2013-05-09
KR101480530B1 (ko) 2015-01-08
HK1139399A1 (sl) 2010-09-17
US20110184008A1 (en) 2011-07-28
US9290491B2 (en) 2016-03-22
TW200845984A (en) 2008-12-01
EP2132204A1 (en) 2009-12-16
CN101616916A (zh) 2009-12-30
US10426766B2 (en) 2019-10-01
PL2132204T3 (pl) 2013-06-28

Similar Documents

Publication Publication Date Title
HUS1900033I1 (hu) Szubsztituált enaminokarbonil vegyületek
IL205066A0 (en) Oxadiazolidinedione compound
ZA200808639B (en) Oxadiazolidinedione compound
GB0706072D0 (en) Compound
EP2361902A4 (en) 4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG
EP1985620A4 (en) COMPOUND 10a-AZALIDE
GB0602778D0 (en) Novel compound
GB0700076D0 (en) Compound
SI2132204T1 (sl) Kristalinične oblike 8-azabiciklo(3.2.1) oktanske spojine
GB0720220D0 (en) Compound
IL200152A0 (en) Aza-bridged-ring compound
EP2000469A4 (en) ACYLAMINOPIPERIDINVERBINDUNG
ZA200903614B (en) New crystalline forms
EP2212305A4 (en) BETA-LACTONE COMPOUNDS
GB0607096D0 (en) Compound
EP2128124A4 (en) NEW HEXATRIENE- -CARBONYL COMPOUND
GB0722779D0 (en) Compound
GB0604142D0 (en) Compound
ZA200806859B (en) Novel crystalline compounds
IL196742A0 (en) Substituted azolin-2-yl-amino compounds
GB0706772D0 (en) Novel compound
GB0625043D0 (en) Novel compound
GB0717335D0 (en) Novel compound
GB0717338D0 (en) Novel compound
GB0720917D0 (en) Novel compound